All Stories

  1. Traumatic Brain Injury in Cameroon: A Prospective Observational Study in a Level I Trauma Centre
  2. The Therapy Intensity Level scale for traumatic brain injury: clinimetric assessment on neuro-monitored patients across 52 European intensive care units
  3. Serum Biomarker Concentrations upon Admission in Acute Traumatic Brain Injury: Associations with TBI Severity, Toxoplasma gondii Infection, and Outcome in a Referral Hospital Setting in Cameroon
  4. Serum Biomarker Concentrations on Admission in Acute Traumatic Brain Injury: Associations with, TBI Severity, <em>Toxoplasma gondii </em>Infection and Outcome in a Referral Hospital Setting, Cameroon
  5. Impact of Sociodemographic, Premorbid, and Injury-Related Factors on Patient-Reported Outcome Trajectories after Traumatic Brain Injury (TBI)
  6. The resilience of a dead brain: commentary to “The intracranial pressure–volume relationship following decompressive hinge craniotomy compared to decompressive craniectomy—a human cadaver study”
  7. Commentary: Prognostic Models for Traumatic Brain Injury Have Good Discrimination But Poor Overall Model Performance for Predicting Mortality and Unfavorable Outcomes
  8. Correction to: Management of moderate to severe traumatic brain injury: an update for the intensivist
  9. Management of moderate to severe traumatic brain injury: an update for the intensivist
  10. Discrepancy between disability and reported well-being after traumatic brain injury
  11. Serum metabolome associated with severity of acute traumatic brain injury
  12. Opportunities and Challenges in High-Quality Contemporary Data Collection in Traumatic Brain Injury: The CENTER-TBI Experience
  13. Burden of Traumatic Brain Injuries in Children and Adolescents in Europe: Hospital Discharges, Deaths and Years of Life Lost
  14. Commentary: The Richmond Acute Subdural Hematoma Score: A Validated Grading Scale to Predict Postoperative Mortality
  15. The Impact of Neurocognitive Functioning on the Course of Posttraumatic Stress Symptoms following Civilian Traumatic Brain Injury
  16. Characteristics, management and outcomes of patients with severe traumatic brain injury in Victoria, Australia compared to United Kingdom and Europe: A comparison between two harmonised prospective cohort studies
  17. Imputation strategies for missing baseline neurological assessment covariates after traumatic brain injury: A CENTER-TBI study
  18. Commentary: Disability Rating Scale in the First Few Weeks After a Severe Traumatic Brain Injury as a Predictor of 6-Month Functional Outcome
  19. Tranexamic acid in traumatic brain injury: systematic review and meta-analysis trumps a large clinical trial?
  20. Prehospital Management of Traumatic Brain Injury across Europe: A CENTER-TBI Study
  21. Preliminary validation of the Dutch version of the Posttraumatic stress disorder checklist for DSM-5 (PCL-5) after traumatic brain injury in a civilian population
  22. Post-Concussion Symptoms in Complicated vs. Uncomplicated Mild Traumatic Brain Injury Patients at Three and Six Months Post-Injury: Results from the CENTER-TBI Study
  23. Adjusting for confounding by indication in observational studies: a case study in traumatic brain injury
  24. Years of life lost due to traumatic brain injury in Europe: A cross-sectional analysis of 16 countries
  25. Letter to the Editor: Complications with cranial perforators
  26. Changing patterns in the epidemiology of traumatic brain injury
  27. Prognosis in moderate and severe traumatic brain injury
  28. Integrated approaches to paediatric neurocritical care in traumatic brain injury
  29. Magnetic resonance imaging improves 3-month outcome prediction in mild traumatic brain injury
  30. Falsely Elevated Sodium Levels During Thiopental Treatment in the ICU: Technical Interference on a Laboratory Device with Important Clinical Relevance
  31. Beware of the Nottingham sheriff when manipulating cerebral blood flow in subarachnoid hemorrhage*
  32. QOLIBRI Overall Scale: a brief index of health-related quality of life after traumatic brain injury
  33. Traumatic Brain and Spinal Cord Injury
  34. Design and analysis of clinical trialsin TBI
  35. Rapid Ventricular Pacing for Flow Arrest During Cerebrovascular Surgery
  36. Predicting 14-Day Mortality after Severe Traumatic Brain Injury: Application of the IMPACT Models in the Brain Trauma Foundation TBI-trac® New York State Database
  37. Prediction of outcome after moderate and severe traumatic brain injury
  38. Prognostic Value of Major Extracranial Injury in Traumatic Brain Injury
  39. Does the Extended Glasgow Outcome Scale Add Value to the Conventional Glasgow Outcome Scale?
  40. Re-Orientation of Clinical Research in Traumatic Brain Injury: Report of an International Workshop on Comparative Effectiveness Research
  41. Spreading depolarisations and outcome after traumatic brain injury: a prospective observational study
  42. Neurologic Emergencies After Neurosurgery
  43. Massive Swelling of Surgicel® Fibrillar™ Hemostat after Spinal Surgery. Case Report and a Review of the Literature
  44. Prognostic Models for Pediatric Head Trauma Still in Their Infancy
  45. Between-centre differences and treatment effects in randomized controlled trials: A case study in traumatic brain injury
  46. Large Between-Center Differences in Outcome After Moderate and Severe Traumatic Brain Injury in the International Mission on Prognosis and Clinical Trial Design in Traumatic Brain Injury (IMPACT) Study
  47. Hypothermia and the complexity of trials in patients with traumatic brain injury
  48. Standardizing Data Collection in Traumatic Brain Injury
  49. The added value of ordinal analysis in clinical trials: an example in traumatic brain injury
  50. Epidemiology of Traumatic Brain Injury
  51. Intensive Care After Neurosurgery
  52. Prognosis after Traumatic Brain Injury
  53. Common Data Elements for Traumatic Brain Injury: Recommendations From the Interagency Working Group on Demographics and Clinical Assessment
  54. Position Statement: Definition of Traumatic Brain Injury
  55. Microsurgical removal of Onyx HD-500 from an aneurysm for relief of brainstem compression
  56. Quality of life after traumatic brain injury: The clinical use of the QOLIBRI, a novel disease-specific instrument
  57. Quality of Life after Brain Injury (QOLIBRI): Scale Development and Metric Properties
  58. Quality of Life after Brain Injury (QOLIBRI): Scale Validity and Correlates of Quality of Life
  59. Noninvasive monitoring of cerebral oxygenation in traumatic brain injury: a mix of doubts and hope
  60. Imminent brain death: point of departure for potential heart-beating organ donor recognition
  61. A simulation study evaluating approaches to the analysis of ordinal outcome data in randomized controlled trials in traumatic brain injury: results from the IMPACT Project
  62. Underpowered trials in critical care medicine: how to deal with them?
  63. Clinical trials in traumatic brain injury: Past experience and current developments
  64. Baseline characteristics and statistical power in randomized controlled trials: Selection, prognostic targeting, or covariate adjustment?*
  65. The Influence of Enrollment Criteria on Recruitment and Outcome Distribution in Traumatic Brain Injury Studies: Results from the Impact Study
  66. Standardisation of data collection in traumatic brain injury: key to the future?
  67. Letters to the Editor
  68. Predicting Outcome after Traumatic Brain Injury: Development and International Validation of Prognostic Scores Based on Admission Characteristics
  69. Moderate and severe traumatic brain injury in adults
  70. Changes of Cerebral Blood Flow during the Secondary Expansion of a Cortical Contusion Assessed by14C-Iodoantipyrine Autoradiography in Mice Using a Non-Invasive Protocol
  71. Classification of Traumatic Brain Injury for Targeted Therapies
  72. Effects of Glasgow Outcome Scale Misclassification on Traumatic Brain Injury Clinical Trials
  73. IMPORTANCE OF SCREENING LOGS IN CLINICAL TRIALS FOR SEVERE TRAUMATIC BRAIN INJURY
  74. Progression of Traumatic Intracerebral Hemorrhage: A Prospective Observational Study
  75. Bryan Jennett and the field of traumatic brain injury. His intellectual and ethical heritage in neuro-intensive care
  76. A systematic review finds methodological improvements necessary for prognostic models in determining traumatic brain injury outcomes
  77. Coagulation disorders after traumatic brain injury
  78. In vitro comparison of two generations of Licox and Neurotrend catheters
  79. Safety and Efficacy of Recombinant Activated Factor VIIa (rFVIIa) in Traumatic Intracerebral Hemorrhage
  80. Prognostic Value of Computerized Tomography Scan Characteristics in Traumatic Brain Injury: Results from The IMPACT Study
  81. IMPACT Database of Traumatic Brain Injury: Design And Description
  82. Multivariable Prognostic Analysis in Traumatic Brain Injury: Results from The IMPACT Study
  83. Prognosis and Clinical Trial Design in Traumatic Brain Injury: The IMPACT Study
  84. Prognostic Value of Admission Blood Pressure in Traumatic Brain Injury: Results from The IMPACT Study
  85. Prognostic Value of Admission Laboratory Parameters in Traumatic Brain Injury: Results from The IMPACT Study
  86. Prognostic Value of Cause of Injury in Traumatic Brain Injury: Results from The IMPACT Study
  87. Prognostic Value of Demographic Characteristics in Traumatic Brain Injury: Results from The IMPACT Study
  88. Prognostic Value of Secondary Insults in Traumatic Brain Injury: Results from The IMPACT Study
  89. Prognostic Value of The Glasgow Coma Scale And Pupil Reactivity in Traumatic Brain Injury Assessed Pre-Hospital And on Enrollment: An IMPACT Analysis
  90. Statistical Approaches to The Univariate Prognostic Analysis of The IMPACT Database on Traumatic Brain Injury
  91. Traumatic brain injury: simple data collection will improve the outcome
  92. Ethical implications of time frames in a randomized controlled trial in acute severe traumatic brain injury
  93. Magnesium for neuroprotection after traumatic brain injury
  94. Monitoring cerebral oxygenation in traumatic brain injury
  95. Armoured brain: case report of a symptomatic calcified chronic subdural haematoma
  96. Adjustment for Strong Predictors of Outcome in Traumatic Brain Injury Trials: 25% Reduction in Sample Size Requirements in the IMPACT Study
  97. Reply to “Organ donation in pediatric traumatic brain injury” by Morris et al.
  98. Some prognostic models for traumatic brain injury were not valid
  99. Is the Glasgow Coma Scale score protected health information?The effect of new United States regulations (HIPAA) on completion of screening logs in emergency research trials
  100. Organ donations and unused potential donations in traumatic brain injury, subarachnoid haemorrhage and intracerebral haemorrhage
  101. The Management of Patients with Intradural Post-Traumatic Mass Lesions: A Multicenter Survey of Current Approaches to Surgical Management in 729 Patients Coordinated by the European Brain Injury Consortium
  102. Combined effects of mechanical and ischemic injury to cortical cells: Secondary ischemia increases damage and decreases effects of neuroprotective agents
  103. Subgroup Analysis and Covariate Adjustment in Randomized Clinical Trials of Traumatic Brain Injury: A Systematic Review
  104. Predicting Outcome after Traumatic Brain Injury: Development and Validation of a Prognostic Score Based on Admission Characteristics
  105. Hyperventilation in Head Injury
  106. Design and Analysis of Phase III Trials with Ordered Outcome Scales: The Concept of the Sliding Dichotomy
  107. Admission of patients with severe and moderate traumatic brain injury to specialized ICU facilities: a search for triage criteria
  108. Ethical considerations on consent procedures for emergency research in severe and moderate traumatic brain injury
  109. Differences in Completion of Screening Logs Between Europe and the United States in an Emergency Phase III Trial Resulting From HIPAA Requirements
  110. New European directive on clinical trials: implications for traumatic head injury research
  111. ‘Treat first, ask later?’ Emergency research in acute neurology and neurotraumatology in the European Union
  112. Patient age and outcome following severe traumatic brain injury: an analysis of 5600 patients
  113. Why Have Recent Trials of Neuroprotective Agents in Head Injury Failed to Show Convincing Efficacy? A Pragmatic Analysis and Theoretical Considerations
  114. Brain tissue oxygen response in severe traumatic brain injury
  115. New European Directive on clinical trials
  116. Serial Transcranial Doppler Measurements in Traumatic Brain Injury with Special Focus on the Early Posttraumatic Period
  117. Regional differences in patient characteristics, case management, and outcomes in traumatic brain injury: experience from the tirilazad trials
  118. Traumatic Brain Injury and Subarachnoid Hemorrhage: In Vivo Occult Pathology Demonstrated by Magnetic Resonance Spectroscopy may not be "Ischaemic". A Primary Study and Review of the Literature
  119. Neuroscience
  120. Traumatic Subarachnoid Hemorrhage: Demographic and Clinical Study of 750 Patients from the European Brain Injury Consortium Survey of Head Injuries
  121. Guidelines for head injury: Their use and limitations
  122. Neuroprotective agents in traumatic brain injury
  123. Intensive care management of head-injured patients in Europe: a survey from the European Brain Injury Consortium
  124. Quality of randomised controlled trials in head injury
  125. CO2 reactivity and brain oxygen pressure monitoring in severe head injury
  126. Brain Oxygen Tension in Severe Head Injury
  127. Assessment of Agents for the Treatment of Head Injury
  128. Failure of the competitive N-methyl-d-aspartate antagonist Selfotel (CGS 19755) in the treatment of severe head injury: results of two Phase III clinical trials
  129. Why Have Recent Trials of Neuroprotective Agents in Head Injury Failed to Show Convincing Efficacy? A Pragmatic Analysis and Theoretical Considerations
  130. The Prognostic Importance of the Volume of Traumatic Epidural and Subdural Haematomas Revisited
  131. The European Brain Injury Consortium Survey of Head Injuries
  132. A multicenter trial on the efficacy of using tirilazad mesylate in cases of head injury
  133. Brain Parenchyma/pO2Catheter Interface: A Histopathological Study in the Rat
  134. The European Brain Injury Consortium
  135. EBIC-Guidelines for management of severe head injury in adults
  136. Continuous Monitoring of Partial Pressure of Brain Tissue Oxygen in Patients with Severe Head Injury
  137. The Rotterdam teletransducer: State of the device
  138. Agreement between physicians on assessment of outcome following severe head injury
  139. Cerebrospinal fluid enzymes in acute brain injury: 3 Effect of hypotension on increase of CSF enzyme activity after cold injury in cats
  140. Cerebrospinal fluid enzymes in acute brain injury. 1. Dynamics of changes in CSF enzyme activity after acute experimental brain injury.
  141. Cerebrospinal fluid enzymes in acute brain injury. 2. Relation of CSF enzyme activity to extent of brain injury.
  142. Severe head injuries in three countries.
  143. Effect of moderate arterial hypotension combined with repeated withdrawal of cerebrospinal fluid on the development of increased ventricular fluid pressure after cold injuries in cats